Month: November 2022

On January 28, 2013, Koreeda, Tetsuro; Kochi, Takuya; Kakiuchi, Fumitoshi published an article.Formula: C12H14F3NO2 The title of the article was Substituent Effects on Stoichiometric and Catalytic Cleavage of Carbon-Nitrogen Bonds in Aniline Derivatives by Ruthenium-Phosphine Complexes. And the article contained the following:

The reactivity of various o-acylaniline derivatives with Ru complexes was examined The reaction of o-acylanilines with RuH2(CO)(PPh3)3 (1) or an activated Ru species formulated as Ru(CO)(PPh3)3 (4) gave amido hydrido complexes 3 and aryl amido complexes, e.g., I (R = H, Me, OMe, F, CF3), formed via N-H and C-N bond cleavage, resp. Addition of olefins, such as vinylsilanes, accelerates the C-N bond cleavage. The aryl amido complexes I can provide the C-N arylation product upon treatment with arylboronates. The relative reactivity of o-acylanilines bearing various substituents was studied by competition experiments, and electron-donating substituents increase the relative facileness of the C-N bond cleavage in both stoichiometric and catalytic reactions. The trend observed here is different from the one observed for the previously reported Ta-mediated C-N bond cleavage. The experimental process involved the reaction of tert-Butyl (4-(trifluoromethyl)phenyl)carbamate(cas: 141940-37-6).Formula: C12H14F3NO2

The Article related to aniline catalytic stoichiometric carbon nitrogen bond cleavage hydridoruthenium phosphine, pivaloylaniline cyclometalation ruthenium hydride complex, ruthenium pivaloylanilido complex preparation catalyst arylation acylaniline and other aspects.Formula: C12H14F3NO2

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Taleb, Assya; Lahrech, Mokhtar; Hacini, Salih; Thibonnet, Jerome; Parrain, Jean-Luc published an article in 2019, the title of the article was RCM vs Oxacycloisomerization through Divergent Reactivity of Dienyl- or Ynenylcycloalkanols using Grubbs Catalyst: an Access to Carbobicycles and Fused Bicyclic Dihydrofurans.Electric Literature of 10472-24-9 And the article contains the following content:

Starting from simple cyclic 1,3-ketoesters like methyl-1-allyl-2-oxocyclopentane-1-carboxylate, ethyl-1-allyl-2-oxocycloheptane-1-carboxylate and ethyl-2-oxo-1-(prop-2-ynyl)cyclohexane-1-carboxylate, etc. a three-step sequence including allylic or propargylic allylation, 1,2-addition reaction of functional Grignard reagent and alkylidene ruthenium-catalyzed cyclization yields to carbobicycles I (R = Me, Et; Q = (CH2)n, n = 1, 2, 3; Y = (CH2)m, m = 0, 1, 2) and/or bicyclic dihydrofurans II (R = Me, Et; Q = (CH2)n, n = 1, 2, 3; Y = (CH2)m, m = 0, 1, 2) or III (R = Me, Et; Q = (CH2)n, n = 1, 2, 3; Y = (CH2)m, m = 0, 1, 2) depending on the nature of theinsatn. (diene or enyne). If the classical ene-ene ring closing metathesis is observed with dienyl substituents IV (R1 = vinyl), similar enynes IV (R1 = ethynyl) led to enyne ring closing metathesis or oxacycloisomerization products depending on the chain length. In the case of ene-yne systems with appropriate longer carbon chains, under the same conditions, metathesis reactions give access to bicyclic dihydrofurans through oxacycloisomerization, demonstrating that it is possible to orient the activity of the Grubbs reagent. The experimental process involved the reaction of Methyl 2-cyclopentanonecarboxylate(cas: 10472-24-9).Electric Literature of 10472-24-9

The Article related to carbobicycle preparation, dienyl cycloalkanol cyclization grubbs catalyst, bicyclo dihydrofuran preparation diastereoselective, diynenyl cycloalkanol cyclization grubbs catalyst, enynyl cycloalkanol cyclization grubbs catalyst and other aspects.Electric Literature of 10472-24-9

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

On March 12, 1998, Picard, Joseph Armand; Sliskovic, Drago Robert published a patent.Computed Properties of 53838-27-0 The title of the patent was Preparation of dibenzofuransulfonyl and related amino acids for inhibition of matrix metalloproteinases. And the patent contained the following:

Heterocyclyl sulfonyl amino acids I (R = unnatural amino acid; X = O, S, SO, SO2, CO, NH, alkyl- or alkylphenylimino; R1, R2 = H, alkyl, Ph, NO2, halo, alkoxy, CN, etc.) or their pharmaceutically acceptable salts, esters, amides, and prodrugs were prepared as matrix metalloproteinases inhibitors. Thus, 6-[2-(4-chlorophenoxy)-2-methylpropionylamino]-2-(dibenzofuran-2-ylsulfonylamino)hexanoic acid, prepared by acylation of 6-amino-2-(dibenzofuran-2-ylsulfonylamino)hexanoic acid Me ester hydrobromide, showed IC50 >100 μM against MMP-1 and MMP-7. The experimental process involved the reaction of (S)-5-tert-Butyl 1-methyl 2-aminopentanedioate(cas: 53838-27-0).Computed Properties of 53838-27-0

The Article related to amino acid dibenzofuransulfonyl dibenzothiophenesulfonyl preparation activity, dibenzofuransulfonyl amino acid preparation inhibitor metalloproteinase, dibenzothiophenesulfonyl amino acid preparation inhibitor metalloproteinase and other aspects.Computed Properties of 53838-27-0

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Van Lysebetten, Dorien; Felissati, Stefania; Antonatou, Eirini; Carrette, Lieselot L. G.; Espeel, Pieter; Focquet, Evelien; Du Prez, Filip E.; Madder, Annemieke published an article in 2018, the title of the article was A thiolactone strategy for straight-forward synthesis of disulfide-linked side-chain-to-tail cyclic peptides featuring an N-terminal modification handle.Name: 3-Aminodihydrothiophen-2(3H)-one hydrochloride And the article contains the following content:

The development of straight-forward and versatile peptide cyclization methods is highly desired to meet the demand for more stable peptide-based drugs. Herein, a new method for the synthesis of side-chain-to-tail cyclic peptides with the simultaneous introduction of an N-terminal handle, based on the introduction of an N-terminal thiolactone building block, is described. A primary amine liberates a homocysteine analog from the thiolactone building block, which further enables cyclization of the peptide through disulfide-bond formation with a C-terminal cysteamine. Postcyclisation modification can be achieved by using small bifunctional amines. Alternatively, the synthesis of lipopeptides is demonstrated through direct thiolactone opening with long-chain alkyl amines. The experimental process involved the reaction of 3-Aminodihydrothiophen-2(3H)-one hydrochloride(cas: 6038-19-3).Name: 3-Aminodihydrothiophen-2(3H)-one hydrochloride

The Article related to cyclic peptide synthesis disulfide thiolactone strategy, solid phase peptide synthesis cyclization aminolysis, lipopeptide synthesis thiolactone ring opening aminolysis, cyclisation, lactones, peptides, sulfur, synthesis design and other aspects.Name: 3-Aminodihydrothiophen-2(3H)-one hydrochloride

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

On November 6, 2008, Sugita, Kazuyuki; Ohtsuka, Masami; Oki, Hitoshi; Haginoya, Noriyasu; Ichikawa, Masanori; Ota, Masahiro; Shibata, Yoshihiro published a patent.Product Details of 141940-37-6 The title of the patent was Preparation of tricyclic heteroaryl compounds as squalene synthetase inhibitors. And the patent contained the following:

There are disclosed 31 specific compounds such as 2-[(4R,6S)-8-chloro-6-(2-chloro-3-ethoxyphenyl)-1-(trifluoromethyl)-4H,6H-[1,2,4]triazolo[4,3-a][4,1]benzoxazepin-4-yl]acetic acid and (2) 2-(1-[2-[(4R,6S)-8-chloro-6-(2-chloro-3-ethoxyphenyl)-1-(trifluoromethyl)-4H,6H-[1,2,4]triazolo[4,3-a][4,1]benzoxazepin-4-yl]acetyl]-4-piperidinyl)acetic acid which have a squalene synthase inhibition activity and a cholesterol synthesis inhibition activity and are useful as medicinal agents such as prophylactic and/or therapeutic agents for hyperlipemia (including hypercholesterolemia, hypertriglyceridemia and hypo-HDL-cholesterolemia) and/or arteriosclerosis in a mammal including human. Thus, Et [trans-5-(2-bromo-3-methoxyphenyl)-7-chloro-2-thioxo-1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl]acetate was condensed with hydrazine hydrate in THF under ice-cooling for 30 min to give a hydrazone which was cyclocondensed with trifluoroacetic anhydride in dichloroethane first at room temperature for 2 h and then under refluxing for 2 h to give Et [trans-6-(2-bromo-3-methoxyphenyl)-8-chloro-1-(trifluoromethyl)-4H,6H-[1,2,4]triazolo[4,3-a][4,1]benzoxazepin-4-yl]acetate (I). Chromatog. resolution of I using a Chiralpak AD column and a 2:8 mixture of isopropanol and hexane as the eluent to give Et [(4R,6S)-6-(2-bromo-3-methoxyphenyl)-8-chloro-1-(trifluoromethyl)-4H,6H-[1,2,4]triazolo[4,3-a][4,1]benzoxazepin-4-yl]acetate (II) and Et [(4S,6R)-6-(2-bromo-3-methoxyphenyl)-8-chloro-1-(trifluoromethyl)-4H,6H-[1,2,4]triazolo[4,3-a][4,1]benzoxazepin-4-yl]acetate. II was stirred with a 4:1 mixture of AcOH and concentrated H2SO4 at 60° for 7 h to give [(4R,6S)-6-(2-bromo-3-methoxyphenyl)-8-chloro-1-(trifluoromethyl)-4H,6H-[1,2,4]triazolo[4,3-a][4,1]benzoxazepin-4-yl]acetic acid (III). III showed IC50 of 0.46 μM against squalene synthase and at 3 mg/kg in vivo inhibited by 98% the synthesis of cholesterol in the liver of rats after 1 h. The experimental process involved the reaction of tert-Butyl (4-(trifluoromethyl)phenyl)carbamate(cas: 141940-37-6).Product Details of 141940-37-6

The Article related to cholesterol synthesis inhibitor triazolobenzoxazepinylacetic acid preparation, tricyclic heteroaryl compound preparation squalene synthetase inhibitor, triazolobenzoxazepinylacetic acid preparation squalene synthetase inhibitor and other aspects.Product Details of 141940-37-6

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

On December 12, 2008, Dragovich, Peter S.; Murphy, Douglas E.; Dao, Kimkim; Kim, Sun Hee; Li, Lian-Sheng; Ruebsam, Frank; Sun, Zhongxiang; Tran, Chinh V.; Xiang, Alan X.; Zhou, Yuefen published an article.Application of 119993-56-5 The title of the article was Efficient synthesis of (1R,2S) and (1S,2R)-2-aminocyclopentanecarboxylic acid ethyl ester derivatives in enantiomerically pure form. And the article contained the following:

A 4-step synthesis of an optically active synthetic intermediate [(1R,2S)-2-(4′-fluorobenzylamino)cyclopentanecarboxylic acid Et ester complex with (S)-(+)-mandelic acid (I), >99% de] required for the preparation of a promising HCV NS5B polymerase inhibitor is reported. This process utilizes mandelic acid as a resolving agent, which can be recovered in good yield by a simple extraction An optimized version of the chem. described avoids the use of chromatog. purifications making it suitable for large-scale applications. In addition, the straightforward conversion of compound I to enantiomerically pure (1R,2S)-2-aminocyclopentanecarboxylic acid Et ester and the corresponding Boc and Cbz derivatives (Boc = tert-butoxycarbonyl, Cbz = benzyloxycarbonyl) is reported. The preparation of the enantiomer of I, compound (II), in enantiomerically pure form and the conversion of this entity to (1S,2R)-2-aminocyclopentanecarboxylic acid Et ester and the corresponding Boc and Cbz derivatives is also described. The experimental process involved the reaction of Ethyl 2-aminocyclopentanecarboxylate hydrochloride(cas: 119993-56-5).Application of 119993-56-5

The Article related to enantiopure amino cyclopentanecarboxylic acid ethyl complex mandelic acid synthesis, aminocyclopentanecarboxylic acid ethyl ester hcv ns5b polymerase inhibitor preparation, mandelic acid resolving agent extraction hydrogenation and other aspects.Application of 119993-56-5

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

On February 9, 2012, Manoharan, Muthiah; Rajeev, Kallanthottathil G.; Yamada, Takeshi; Butler, David; Jayaprakash, K. Narayanannair; Jayraman, Muthusamy; Matsuda, Shigeo; Pandey, Rajendra K.; Peng, Chang Geng published a patent.Computed Properties of 53838-27-0 The title of the patent was Preparation of monomers and oligonucleotides comprising triazolyl cycloaddition adducts via click chemical for treating various disorders and diseases. And the patent contained the following:

Oligonucleotides monomers I were prepared and incorporated into RNA, wherein X is O, S, NRN, CRP2; B is independently H, nucleobase, triazole; NH-C(O)-O-C(CH2B1)3, NH-C(O)-NH-C(CH2B1)3; where B1 is halogen, mesylate, N3, CN, triazole, tetrazole; R1-R5 are each independently H, OR6, F, N(RN)2, N3, CN, -J-linker-N3, -J-linker-CN, -J-linker-C-R8, -J-linker-cycloalkyne, -J-cycloalkylidene-linker, -J-heterocyclyl-linker; J is independently absent, O, S, NRN, OC(O)NH, NHC(O)O,C(O)NH, NHC(O), NHSO, NHSO2, NHSO2NH, OC(O), C(O)O, OC(O)O, NHC(O)NH, NHC(S)-NH, OC(S)-NH, O-N=CH, OP(N(RN)2)O, or OP(N(RN)2); R6 is independently H, hydroxy protecting group, alkyl, aryl, cycloalkyl, aralkyl, alkenyl, heteroaryl, polyethylene glycol, phosphate, phosphonate, phosphonothioate, phosphorothiolothionate, phosphodiester, phosphoramidite, solid support, nucleoside, oligonucleotide; RN is independently H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, aralkyl, heteroaryl, amino protecting group; RP is independently H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heteroaryl. Thus, glycoside II was prepared and used in synthesis of DNA duplexes synthesis. The invention further relates to methods for treating various disorders and diseases such as viral infections, bacterial infections, parasitic infections, cancers, allergies, autoimmune diseases, immuno-deficiencies and immunosuppression. The experimental process involved the reaction of (S)-5-tert-Butyl 1-methyl 2-aminopentanedioate(cas: 53838-27-0).Computed Properties of 53838-27-0

The Article related to lipid azide preparation click alkyne rna preparation antiviral human, antiviral parasiticide antitumor immunosuppression autoimmune rna dna duplex preparation, click azide alkyne triazole nucleotide preparation sirna dna peptide and other aspects.Computed Properties of 53838-27-0

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Medici, Antonio; Saviano, Lorenzo; Siciliano, Antonietta; Libralato, Giovanni; Guida, Marco; Previtera, Lucio; Di Fabio, Giovanni; Zarrelli, Armando published an article in 2022, the title of the article was Octocrylene: From Sunscreens to the Degradation Pathway during Chlorination Processes: Formation of Byproducts and Their Ecotoxicity Assessment.Product Details of 6197-30-4 And the article contains the following content:

Octocrylene is an organic sunscreen whose main action is to absorb UVB radiation and short UVA wavelengths; it is used in various cosmetic products in order to provide an adequate sun-protection factor or to protect the cosmetic formulations themselves from UV radiation. This filter is believed to be a possible endocrine disruptor and is also questioned due to its allergic and/or photoallergic potential. However, it continues to be widely used, and it has been found in various environments, not least those of swimming pools, where it is evidently released by consumers, to the point that it is now considered an emerging micropollutant. The present investigation presents the possible chem. fate of octocrylene in the typical chlorination conditions of wastewater or swimming pools. A total of 11 disinfection byproducts were identified, and 6 were identified for the first time, and separated by HPLC. These products were identified through careful mass spectrometry studies and 1D and 2D NMR experiments A formation mechanism has been proposed that justifies the chem. structures of all of the compounds identified. The ecotoxicol. assessment of octocrylene and their products was carried out by employing Phaeodactylum tricornutum, Brachionus plicatilis and Aliivibrio fischeri as bioindicators. The ecotoxicity results reveal that toxic byproducts might be generated during the oxidation process, increasing the potential risk to the marine environment. The experimental process involved the reaction of 2-Ethylhexyl 2-cyano-3,3-diphenylacrylate(cas: 6197-30-4).Product Details of 6197-30-4

The Article related to octocrylene byproduct ecotoxicity assessment sunscreen chlorination process, aliivibrio fischeri, brachionus plicatilis, phaeodactylum tricornutum, chlorination, degradation byproducts, hypochlorite, octocrylene, water treatment and other aspects.Product Details of 6197-30-4

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Winterson, Bethan; Rennigholtz, Tim; Wirth, Thomas published an article in 2021, the title of the article was Flow electrochemistry: a safe tool for fluorine chemistry.Recommanded Product: (2R,3S,4R)-2-(Acetoxymethyl)-3,4-dihydro-2H-pyran-3,4-diyl diacetate And the article contains the following content:

A scalable, versatile and safe electrochem. fluorination protocol was conferred and strategy proceeded through a transient (difluoroiodo)arene, generated by anodic oxidation of an iodoarene mediator. Even the isolation of iodine(III) difluorides was facile since electrolysis was performed in the absence of other reagents. A broad range of hypervalent iodine mediated reactions afforded 5-(fluoromethyl)-aryl-oxazolines [R = Ph, 2-furanyl, 4-MeOC6H4, etc.], ((2,3-difluoropropoxy)methyl)-aromatic compounds [R1 = Ph, 2-MeC6H4, 4-FC6H4, etc.; R2 = H, Me] and some fluoro compounds R3-F [R3 = 1,3-diphenylpropanyl-1,3-dione, 1-phenyl-1-propanone, 3-phenyldihydrofuran-2(3H)-one, etc.] in high yields by coupling the electrolysis step with downstream reactions in flow, surpassing limitations of batch chem. (Difluoroiodo)arenes were toxic and suffered from chem. instability, so the uninterrupted generation and immediate use in flow was highly advantageous. High flow rates facilitated productivities of up to 834 mg h-1 with vastly reduced reaction times. Integration into a fully automated machine and in-line quenching was key in reducing the hazards surrounding the use of hydrofluoric acid. The experimental process involved the reaction of (2R,3S,4R)-2-(Acetoxymethyl)-3,4-dihydro-2H-pyran-3,4-diyl diacetate(cas: 2873-29-2).Recommanded Product: (2R,3S,4R)-2-(Acetoxymethyl)-3,4-dihydro-2H-pyran-3,4-diyl diacetate

The Article related to fluoro compound preparation, allyl amide electrochem fluorination hypervalent iodine mediated, alc allyl electrochem fluorination hypervalent iodine mediated, carbonyl compound electrochem fluorination hypervalent iodine mediated and other aspects.Recommanded Product: (2R,3S,4R)-2-(Acetoxymethyl)-3,4-dihydro-2H-pyran-3,4-diyl diacetate

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

On July 31, 2022, Li, Xiang; Liu, Hui; Dun, Matthew D.; Faulkner, Sam; Liu, Xiaoming; Jiang, Chen Chen; Hondermarck, Hubert published an article.Synthetic Route of 2358-84-1 The title of the article was Proteome and secretome analysis of pancreatic cancer cells. And the article contained the following:

Pancreatic cancer is a lethal malignancy and no screening biomarker or targeted therapy is currently available. Here, we performed a shotgun proteomic label-free quantification (LFQ) to define protein changes in the cellular proteome and secretome of four pancreatic cancer cell lines (PANC1, Paca44, Paca2, and BXPC3) vs. normal human pancreatic ductal epithelial cells (HPDE). In the cellular proteome and secretome, 149 and 43 proteins were dysregulated in the most cancer cell lines, resp. Using Ingenuity Pathway Anal. (IPA), the most dysregulated signaling pathways in pancreatic cancer cells included the activation of epidermal growth factor receptor (EGFR), phosphoinositide 3-kinase (PI3K), protein kinase B (AKT), extracellular regulated kinase (ERK), and the deactivation of type-I interferon (IFN) pathways, which could promote cancer cell progression and decrease antitumor immunity. Parallel reaction monitoring (PRM) mass spectrometry was used to confirm the changes of seven regulated proteins quantified by LFQ: EGFR, growth/differentiation factor 15 (GDF15), protein-glutamine gamma-glutamyltransferase 2 (TGM2), leukemia inhibitory factor (LIF), interferon-induced GTP-binding protein Mx1 (MX1), signal transducer and activator of transcription 1 (STAT1), and serpin B5 (SERPINB5). Together, this proteomic anal. highlights protein changes associated with pancreatic cancer cells that should be further investigated as potential biomarkers or therapeutic targets. The experimental process involved the reaction of Oxybis(ethane-2,1-diyl) bis(2-methylacrylate)(cas: 2358-84-1).Synthetic Route of 2358-84-1

The Article related to pancreatic cancer proteome secretome type i interferon serpinb5 tgm2, lc-ms/ms, prm proteomic, biomarker, label-free quantification, pancreatic cancer, pathway analysis, proteome, secretome, shotgun proteomic, therapeutic targets and other aspects.Synthetic Route of 2358-84-1

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics